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GB virus-B (GBV-B) is a member of the Flaviviridae family of viruses. This RNA virus infects tamarins, but its natural host
is not known. GBV-B has special interest because it is the virus that is most closely related to hepatitis C virus (HCV), an
important human pathogen. In the present study, we identified a previously unrecognized sequence at the 39 end of the GBV-B
genome. This new 39 terminal sequence can form several predicted stem-loop structures as is typical for other members of
the Flaviviridae family. We constructed molecular clones and showed that the new 39 UTR sequence was critical for in vivo
infectivity. After intrahepatic transfection of two tamarins with RNA transcripts of the full-length GBV-B clone, we detected
high viral titers from Week 1 postinoculation with peak titers of ;108 genome equivalents/ml. The viremic pattern of GBV-B
infection in the transfected animals was the same as in animals inoculated intravenously with the virus pool used as the
cloning source. The sequence of the recombinant virus was recovered from one of the tamarins and shown to be identical
to that of the infectious clone. The development of severe hepatitis in both tamarins infected with the recombinant GBV-B
virus provides formal proof that GBV-B is a true hepatitis virus. © 1999 Academic Press
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Transmission studies of potential human hepatitis
gents were reported in 1967 (Deinhardt et al., 1967).
our tamarins inoculated with acute-phase serum from a
urgeon with acute hepatitis (Patient GB) developed hep-
titis, as did most tamarins inoculated in serial passage
tudies. Subsequent studies indicated that the etiologi-
al agent responsible for the development of hepatitis in
hese animals was not any of the known human hepatitis
iruses (Purcell, 1993). In 1995, two related RNA viruses
amed GB virus-A (GBV-A) and GB virus-B (GBV-B) were
dentified in acute phase sera of a tamarin that devel-
ped hepatitis after inoculation with serum of the 11th
amarin passage of the putative GB agent (Simons et al.,
995b). GBV-B infection of tamarins resulted in acute
esolving hepatitis (Schlauder et al., 1995). The natural
ost of GBV-B is still unknown because it has not been
etected in uninoculated animals or in humans. In con-
rast, GBV-A is an indigenous tamarin virus rather than a
omponent of the original GB inoculum (Bukh and Apgar,
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470997; Erker et al., 1998). Experimental infection of tama-
ins with GBV-A did not cause hepatitis (Schlauder et al.,
995). Subsequently, a human agent, GBV-C or hepatitis
virus, closely related to GBV-A, was identified (Simons
t al., 1995a; Linnen et al., 1996). It is still not clear
hether this virus actually causes hepatitis, but it most
ikely does not (Alter et al., 1997; Bukh et al., 1998b). Thus
mong the GB viruses only GBV-B may be a true hepatitis
irus.
Based on analysis of their genomic sequences,
BV-A, GBV-B, and GBV-C were classified as members
f the Flaviviridae family (flaviviruses, pestiviruses, and
epacivirus; Rice, 1996). GBV-B is of particular interest
ecause among the known viruses, it is the virus most
losely related to hepatitis C virus (HCV) (Muerhoff et al.,
995; Erker et al., 1998; Robertson et al., 1998), which is
n important human pathogen (Houghton, 1996). The
BV-B virus contains a positive-sense, single-stranded
NA genome of 9143 nts (Muerhoff et al., 1995; Simons et
l., 1995b). A single long open reading frame (ORF) is
racketed by 59 and 39 untranslated regions (UTR).
ased on known motifs, structural proteins were pre-
icted to be encoded in the 59 portion of the ORF and
onstructural (NS) proteins in the 39 portion of the ORF
Muerhoff et al., 1995). The hydropathy plots of the
olyproteins of GBV-B and HCV are very similar even
hough the overall homology of the predicted polypro-
eins between GBV-B and HCV is only ;25–30% (Muer-
off et al., 1995). The putative envelope proteins (E1 and
2) of GBV-B and HCV share common structural features.
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471INFECTIOUS CLONE OF GB VIRUS-Burthermore significant homology was observed among
he NS3 serine protease, the NS3 RNA helicase, the NS5
NA-dependent RNA polymerase regions, and the con-
ensus sequences at the predicted cleavage sites in the
S regions, respectively, of GBV-B and HCV (Muerhoff et
l., 1995). The function and substrate specificity of the
BV-B and HCV NS3 serine proteases are also similar
Scarselli et al., 1997). The genomic structure and orga-
ization of GBV-B and HCV share additional features of
nterest. First, colinear regions with significant sequence
omology were identified in the 59 UTRs (Muerhoff et al.,
995). The predicted internal ribosome entry site (IRES)
tructure of GBV-B is similar to that of HCV (Lemon and
onda, 1997). Second, both viruses begin the 39 UTR
ith a short sequence followed by a poly(U) stretch
ollowed by additional nucleotides (49 nts for GBV-B and
8 nts for HCV). Whereas the 39 terminal sequence of
CV forms a stable stem-loop structure (Tanaka et al.,
995, Kolykhalov et al., 1996), this was not the case for
he published 39 terminal sequence of GBV-B.
Despite the recent development of infectious clones of
CV (Kolykhalov et al., 1997; Yanagi et al., 1997, 1998),
olecular studies are severely limited by the lack of an
fficient cell culture system for this virus and by the
bsence of a small animal model. We are exploring the
ossibility of using experimental infections of tamarins
ith GBV-B as a surrogate model for the study of HCV. In
he present study, a detailed sequence analysis of the
omplete genome of GBV-B led to the identification of
dditional 39 terminal sequence. A molecular clone of
BV-B that contained this new sequence was infectious
n vivo.
RESULTS
ourse of GBV-B in experimentally infected tamarins
To generate virus pools of the GB agent, we inoculated
amarins intravenously with pooled sera of the 11th
amarin passage of this agent. Acute phase serum from
ne Saguinus mystax tamarin that developed hepatitis
as pooled (GB 8/93) and inoculated into additional S.
ystax tamarins to generate a second pool of acute
hase serum (GB 2/94). Each serum pool contained
108 genome equivalents (GE)/ml of GBV-B. A 10% liver
omogenate (CT 11/91) was prepared from one S. oedi-
us tamarin that developed hepatitis following inocula-
ion with the 12th passage of the GB agent. The titer of
BV-B in the liver homogenate was ;107 GE/ml. The GB
/94 serum and CT 11/91 liver samples were used as
BV-B-cloning sources in the present study.
Inoculation of eight S. mystax tamarins with 10-fold
erial dilutions of the GB 2/94 pool demonstrated that its
nfectivity titer for GBV-B was 108 tamarin 50% infectious
oses (TID50) (Fig. 1). The five GBV-B-infected tamarins
ll developed acute resolving hepatitis characterized by
arly appearance of viremia (Weeks 1 or 2 postinocula- sion), peak viral titers of 107–108 GE/ml and clearance of
iremia after 9–16 weeks (Fig. 1). A single S. mystax
amarin inoculated with the liver homogenate also devel-
ped acute resolving hepatitis with peak GBV-B titers of
07 GE/ml and clearance of viremia after 11 weeks. The
nfectivity titer of GBV-B in the GB 8/93 pool was 106.5
ID50. The four infected S. mystax inoculated with dilu-
ions of this pool had acute resolving hepatitis with
learance of the GBV-B virus after 11–26 weeks. Thus the
atural history of GBV-B in S. mystax tamarins was char-
cterized by acute hepatitis, early appearance of viremia,
igh peak viral titers, and viral clearance. There was a
ood correlation between infectivity titer and GBV-B ge-
ome titer; one TID50 was equivalent to one GE in the GB
/94 pool and to 32 GE in the GB 8/93 pool.
equence analysis of the GBV-B cloning source:
iscovery of a novel 39 terminal sequence
The consensus sequence of the complete 59 UTR of
BV-B (nts 1–445) was deduced from 13 clones contain-
ng nts 1–283 and 3 clones containing nts 31–445. In
ddition, the entire 59 UTR sequence was determined by
irect sequencing of the amplicons. The sequence of the
arious clones was highly conserved and the consensus
9 UTR sequence of GBV-B from this pool was identical
o that published previously for GBV-B (Simons et al.,
995b). It is noteworthy that 13 of 15 clones analyzed
rom the 59 RACE procedure contained the published
BV-B 59 terminus (A residue) and that the same 59
erminus was obtained whether the 59 RACE was per-
ormed with dC or dA tailing.
The consensus sequence of the ORF (nts 446–9037)
as determined by direct sequencing of PCR products
btained by using long RT–PCR (Yanagi et al., 1997). In
ddition, we analyzed three clones containing nts 446–
135 (one of these clones had a deletion of nts 3041–
643), two clones containing nts 2019–3373, 5 clones
ontaining nts 7151–8261, and 7 clones containing nts
521–9037. The sequence of GBV-B in this pool was very
omogeneous. Evidence of microheterogeneity was
ound at only 70 (0.8%) nucleotide and 36 (1.3%) amino
cid positions, scattered throughout the ORF. The pro-
ortion of amino acid positions with heterogeneity
anged from 0.5–2.6% in different putative gene regions
lowest in NS5B; highest in E2). The GBV-B ORF se-
uence differed from the published sequence of GBV-B
Simons et al., 1995b) at 34 (0.4%) and 12 (0.4%) nucleo-
ide and deduced amino acid positions, respectively (Ta-
le 1).
The consensus sequence we determined for the 39
TR of GBV-B is shown in Fig. 2. The sequences among
he various 39 UTR clones analyzed were highly con-
erved with only three mutations found downstream of
he poly(U) tract. We initially identified additional 39 UTR
equence by performing RT–PCR across 59-to-39-end-
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472 BUKH, APGAR, AND YANAGIigated viral RNA, extracted from serum. In all of four
lones with GBV-B sequences, the 59 UTR was truncated.
owever, whereas one clone had the exact 39 terminus
reviously published by Simons et al. (1995b), the three
ther clones had 150 additional terminal nucleotides.
ompared with the sequence previously published, all
our clones had a single nucleotide insertion (C residue)
t position 9134. We next performed 59 RACE (using
C-tailing only) on the 59 end of the negative-strand RNA
xtracted from the liver homogenate. We analyzed 11
lones and found that all had additional sequences at
he 39 terminus. Compared with the published GBV-B
equence two clones had 259 additional nucleotides, 8
FIG. 1. Course of GBV-B infection in tamarins (S. mystax) inoculate
ntravenously at Week 0 with 1 ml of the indicated dilution. Results of qu
ositive; empty circles, negative). Serum levels of isocitrate dehydrog
vertical columns) were plotted against time. Two tamarins that were in
one of the eight tamarins became infected with GBV-A, which was p
BV-ASM, a GBV-A variant indigenous to S. mystax, before inoculationlones had 237 additional nucleotides, and 1 clone had w33 additional nucleotides. Also, all of these clones had
he insertion at position 9134. To demonstrate that the
erminal 22 nucleotides found only in the two longest
lones existed in circulating viruses, we performed RT-
ested PCR on 10-fold serially diluted RNA extracted
rom the serum pool GB 2/94 using an RT and external
ntisense primer deduced from this sequence. We de-
ected GBV-B RNA at a dilution of 1027 (a 1028 dilution
as detected with the 59 UTR primers) and the sequence
f the amplicon was identical to the sequence recovered
rom the liver homogenate. Thus the 39 UTR of GBV-B
onsists of a short sequence of 30 nts followed by an
1–24 nucleotide-long poly(U) tract (single C residues
a dilution series of the pool GB 2/94. All animals were inoculated
RT-nested PCR for GBV-B in serum are shown at the top (filled circles,
[ICD (U/ml); shaded area) and the estimated log10 GBV-B GE titer/ml
d with 1029 dilutions of the pool and were not infected are not shown.
in the GB 2/94 pool. S. mystax 750, 760, and 782 were infected with
t al., 1997).d with
alitative
enase
oculate
resentere observed in GBV-B from the liver homogenate) and
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473INFECTIOUS CLONE OF GB VIRUS-B39 terminal sequence of at least 309 nts. A “Blast”
earch indicated that the new GBV-B 39 UTR sequence
id not have significant homology to any of the se-
uences deposited in the GenBank database. A predic-
T
Nucleotide and Amino Acid Differences Among GBV-B (Simons et al
Used as the Cloning Source (GBV-B, 2/9
Genomic regiona
Position N
nt [aa] GBV-B G
9 UTR (1–445)
(446–913)
1 (914–1489) 1030 C
2 (1490–2641) 1498 T
1628 [395] G
2552 [703] G
2562, 2563 [706] C, A
2566 T
2625 [727] C
S2 (2642–3265) 2647 C
2816 [791] C
2855 [804] A
3235 A
S3 (3266–5125) 3475b C
3760 C
4114 C
4117 C
4177 T
4615 C
S4A (5126–5290)
S4B (5291–6034) 5329 C
5332 T
5350 A
5455 C
S5A (6035–7267) 6413 [1990] T
6577 G
6690 [2082] T
6965 [2174] T
7015 A
7128 [2228] G
7138b A
7142 [2233] A
S5B (7268–9037) 7282 T
7849 C
7852 C
8942 [2833] G
8971 T
9026 C
9 UTR (9038–9399) 9061 T
Poly (U) 27 nts
9134 Deletion
9141–9399 ND
Note. ND: Not determined. Nucleotides and amino acids shown in pa
a Nucleotide positions corresponding to pGBB. Putative gene borders
t al., 1997).
b Positions that differ between the cloning source (GBV-B 2/94) and
osition 7138 introduced an artificial SalI site.ion of the secondary structure of the 39 UTR sequence is vhown in Fig. 2. Inclusion of the GBV-B 59 UTR sequence
n the analysis did not disrupt the putative stem-loop
tructures at the 39 end. Most notable is a highly stable
tem-loop structure, consisting of 47 nucleotides, at the
), the Consensus Sequence of GBV-B Recovered from a Virus Pool
the Infectious Clone of GBV-B (pGBB)
ide Amino acid
2/94 pGBB GBV-B GBV-B, 2/94 pGBB
T
C
A V I (V) I
A D N (D) N
A, C P H H
C
T A V V
T
T L F F
G T A A
G
T
T
T
A
C
T
T
C
C
T
A L M (L) M
T
C I T (I) T
C S P (S) P
G
A G E E
G
G T A A
C
A
T
A V I (V) I
C
T
C
nts 23 nts
C
259 nts
sis were found as a minor species in the cloning source (GBV-B, 2/94).
d as suggested by homology with HCV (Muerhoff et al., 1995; Scarselli
ectious clone of GBV-B (pGBB). The change introduced into pGBB atABLE 1
. 1995b
4) and
ucleot
BV-B,
T
C (t)
A (g)
A (g)
A, C
C
T
T (c)
T
G
G (a)
C (t)
T (c)
T
A
C
T
T
C
C
T (c)
A (t)
T
C (t)
C (t)
G (a)
A
A
G
C (t)
A
T
A (g)
C
T (c)
C
11–23
C
259 nts
renthe
define
the infery 39 end.
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474 BUKH, APGAR, AND YANAGImolecular clone of GBV-B is infectious in vivo
We first tested the infectivity of RNA transcripts from
he consensus clone pGBB5–1, which encompassed only
he GBV-B sequence previously published (Simons et al.,
995b). Within the GBV-B sequence there were no de-
uced amino acid differences and only two nucleotide
ifferences (at nucleotide positions 3475 and 7138) from
he consensus sequence of GBV-B as determined in the
resent study. In addition, in the 39 UTR this clone had a
eletion at nucleotide position 9134 and was missing the
9 terminal 259 nts. Before transcription, the pGBB5–1
lone was linearized at the BamHI site with digestion at
he exact GBV-B 39 terminus. The RNA transcripts from
GGB5–1 were injected into the liver of two tamarins (S.
ystax 797 and 815). However, we did not detect GBV-B
NA in weekly serum samples collected during 17
eeks of follow-up. Furthermore both tamarins had nor-
al liver enzyme values throughout follow-up. The sus-
eptibility of the two tamarins to GBV-B was subse-
uently demonstrated by experimental infection using a
BV-B virus pool. Thus this consensus clone was not
nfectious in vivo.
We next tested the infectivity of RNA transcripts from a
onsensus cDNA clone of GBV-B (pGBB) which included
he nucleotide insertion at position 9134 and the addi-
ional 259 nts at the 39 terminus. Except for the new 39
TR sequence inserted, this clone was identical to
GBB5–1. Thus this cDNA clone of GBV-B contained a 59
TR of 445 nts, an ORF of 8592 nts encoding 2864 amino
FIG. 2. Predicted secondary structures of the 39 UTR of GBV-B and t
re those of the infectious clone of GBV-B (pGBB) and an infectious clon
ith the program “mFold” (Genetics Computer Group). The energy for th
s 257.8 kcal/mol. The energy for the very 39 terminal stem-loop struccids and a 39 UTR of 362 nts (short sequence of 30 nts vollowed by a 23-nucleotide-long poly(U) tract and the 39
erminal sequence of 309 nts). pGBB was linearized at
he XhoI site, which added up to five extra residues at the
9 end of the transcribed GBV-B RNA. When RNA tran-
cripts from the pGBB clone were injected into the liver
f two tamarins (S. mystax 816 and 817) both became
nfected with GBV-B, with viremia at Week 1 postinocu-
ation and peak viral titers of 108 GE/ml (Fig. 3). The
onsensus sequence of PCR products of the complete
RF, amplified from serum obtained during Week 2 post-
noculation from one tamarin (S. mystax 817), was iden-
ical to the sequence of pGBB, including at the two
ositions that differed from the consensus sequence of
he cloning source and from the published sequence of
BV-B (Table 1). We demonstrated, using RT–PCR as
escribed above, that the very 39 terminal GBV-B se-
uence of pGBB existed in the circulating viruses in this
amarin. Within 3 weeks of the transfection, both tama-
ins developed hepatitis with dramatically elevated se-
um liver enzyme levels and necroinflammatory changes
n liver biopsy samples (Fig. 3). The GBV-B infection was
esolved in both animals (Fig. 3).
DISCUSSION
The agent GBV-B, a virus of unknown origin, infects
amarins. In the present study, we confirmed the se-
uence of the GBV-B 59 terminus previously published by
imons et al. (1995b) and identified additional nucleo-
ides at the 39 terminus of GBV-B. The 39 terminus pre-
TR (with upstream NS5B sequence) of HCV. The sequences analyzed
V strain H77 (pCV-H77C; Yanagi et al., 1997). Analyses were performed
ure of GBV-B is -105.7 kcal/mol and the energy for the structure of HCV
GBV-B and HCV are 223.8 and 225.5 kcal/mol, respectively.he 39 U
e of HC
e structiously published by Simons et al. (1995b) was lacking
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475INFECTIOUS CLONE OF GB VIRUS-Befined secondary structures typical for flaviviruses, pes-
iviruses, and HCV (Kolykhalov et al., 1996). However, the
9 UTR with the additional nucleotides could potentially
orm several putative stem-loop structures; the 39 termi-
al 47 nucleotides form a highly stable stem-loop struc-
ure. The additional sequence was critical for infectivity
f an infectious molecular consensus clone of GBV-B
pGBB); an identical molecular clone lacking the new 39
TR sequence was not infectious.
Because of the lack of cell cultures known to support
he replication of GBV-B, we tested infectivity of RNA
ranscripts from the molecular clones in vivo, as previ-
usly established for RNA transcripts of infectious
lones of hepatitis A virus in tamarins (Emerson et al.,
992) and HCV in chimpanzees (Kolykhalov et al., 1997;
anagi et al., 1997). After transfection of tamarins with the
horter clone (pGBB5–1), we did not detect viremia dur-
ng 17 weeks of follow-up, indicating that the clone was
ot infectious. In contrast, transfection with an equivalent
mount of RNA transcripts of the longer clone (pGBB)
roduced high viral titers beginning by Week 1 postin-
culation. The sequence of the recombinant virus was
ecovered from one of the tamarins and shown to be
dentical to that of the infectious clone.
A clear association between experimental infection
ith GBV-B and the development of acute hepatitis in
amarins was previously demonstrated (Schlauder et al.,
995; Bukh et al., 1997). However, as illustrated by the
imultaneous transmission of GBV-A from the GB-agent
ools (Schlauder et al., 1995; Bukh et al., 1997), other
nrecognized viruses could have been passaged as well
nd theoretically could have caused the hepatitis. The
evelopment of hepatitis in both tamarins transfected
ith the recombinant GBV-B transcripts provides formal
roof of GBV-B as the disease-causing agent. The pat-
ern of GBV-B infection in animals inoculated intrave-
FIG. 3. Course of GBV-B infection in S. mystax tamarins transfected w
transcription mixtures were injected into tamarins by percutaneous int
or GBV-B RNA in serum (filled circles, positive; empty circles, negative)
s 0 (no change), 11, 21, 31, and 41] are shown at the top. Serum lev
og10 GBV-B GE titer/ml (vertical columns) were plotted against time.ously with the virus pool used as the cloning source sas the same as that of transfected animals and was
haracterized by early appearance of viremia, peak viral
iters of ;108 GE/ml, and viral clearance.
The infection of tamarins with GBV-B could potentially
erve as a surrogate animal model for infection of hu-
ans with HCV; this important human pathogen, which
auses liver disease worldwide, can be propagated only
n chimpanzees. GBV-B is a logical first choice because
t is the virus most closely related to HCV and it infects
amarins, which are more readily available than chim-
anzees. There are, however, important differences in
he natural history of HCV and GBV-B in their respective
nimal hosts. Although both HCV and GBV-B cause
cute hepatitis, acute hepatitis after infection of chim-
anzees (and humans) is most often not seen until .8
eeks postinoculation. Conversely, GBV-B causes acute
epatitis in experimentally infected tamarins as early as
week postinoculation. However, the most important
ifference is that HCV infection often becomes chronic,
hereas GBV-B infection is apparently resolved in all
ases.
From a virological point of view, there are also impor-
ant similarities and differences between HCV and
BV-B. HCV is so genetically heterogeneous that it is
ivided into at least six major genotypes with multiple
ubtypes and displays a quasispecies distribution in an
nfected host (reviewed in Bukh et al., 1995). Furthermore
CV has a hypervariable region in the E2 protein be-
ieved to be of importance for viral persistence. In con-
rast, only one viral strain of GBV-B has been identified. In
he present study, we found that the virus populations of
BV-B in an acute phase virus pool generated from three
nfected tamarins were quite homogeneous. Although
e did not find evidence of hypervariable regions, we did
bserve several differences between the GBV-B se-
uence of this virus pool compared with the published
transcripts of pGBB. Both animals were negative for GBV-ASM. At Week
tic injection guided by ultrasound. Results of qualitative RT-nested PCR
amination of liver biopsy samples [necroinflammatory changes graded
isocitrate dehydrogenase [ICD (U/ml); shaded area] and the estimatedith RNA
rahepa
and ex
els ofequence (Simons et al., 1995b).
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476 BUKH, APGAR, AND YANAGIPerhaps the most important application of the GBV-B
odel is the possibility of indirectly or directly study-
ng the molecular biology of HCV. This could be done
y studying motifs that are conserved between these
iruses (Muerhoff et al., 1995; Scarselli et al., 1997);
utagenesis in the GBV-B clone would be followed by
he determination of infectivity for tamarins. Alterna-
ively, the construction of GBV-B chimeras containing
CV elements would permit analysis of HCV elements
n vivo. For instance, chimeric viruses might potentially
erve as a model for testing HCV protease, helicase,
r polymerase inhibitors as well as therapeutic agents
hat target the UTR regions or their interaction with
ost or viral factors. The 59 UTR of both viruses contain
RES-like structures (Lemon and Honda, 1997). We
ound that uncapped GBV-B RNA was infectious, sug-
esting that cap-independent translation initiation via
he IRES is used for gene expression in vivo. It was
ecently found that the IRES of poliovirus or bovine
iral diarrhea virus could be replaced with that of HCV
Lu and Wimmer, 1996; Frolov et al., 1998; Zhao et al.,
999). Thus it might very well be possible to make
imilar chimeras between GBV-B and HCV and study
RES function in vivo.
The composition of the 39 UTR of GBV-B is most similar
o that of HCV. A short sequence after the ORF termina-
ion codon is followed by a poly(U) tract and additional
equence at the 39 terminus. Except for the poly(U) tract,
owever, the 39 UTR sequence of GBV-B shows no sig-
ificant homology with the 39 UTR of HCV or any other
equences in the GenBank database. The poly(U) tract in
BV-B is much shorter than that of HCV. The sequence
fter the poly(U) tract is three times longer in GBV-B (309
ts) than in HCV (98 nts). Importantly, however, the 39
TR of both of these viruses can form a similar stem-loop
tructure at the very 39 end, consisting of 47 nts in GBV-B
nd 46 nts in HCV (Fig. 2). We recently demonstrated that
his 39 terminal stem-loop structure is critical for infec-
ivity of HCV in vivo (Yanagi et al., 1999). The availability
f infectious clones of both GBV-B and HCV should
ermit more detailed analysis of these 39 UTR se-
uences, which are believed to be important for initiation
f RNA replication.
In summary, we have determined the complete se-
uence of GBV-B, a member of the Flaviviridae family of
iruses that infects tamarins, and have constructed a
enetically stable infectious molecular clone. Infection of
amarins with recombinant GBV-B virus results in the
evelopment of acute hepatitis. Because GBV-B is the
irus most closely related to HCV, the availability of this
ew GBV-B infectious clone could represent an impor-
ant tool for the study of the molecular biology of HCV
nd for the development of therapeutics for this impor-ant human pathogen. 5MATERIALS AND METHODS
ource of GBV-B
Two pools of tamarin serum containing GBV-A and
BV-B [VR-806 (American Type Culture Collection) and
205], supplied by the late Prof. F. Deinhardt, were used
or experimental transmission of the GB agents.
mplification, cloning, and sequence analysis
f GBV-B
Viral RNA was extracted from 10 to 100 ml of serum or
iver homogenate with the TRIzol system (GIBCO/BRL).
he RNA pellet was resuspended in 10 mM dithiothreitol
DTT) containing 5% (vol/vol) of RNAsin (20–40 u/ml) (Pro-
ega). Primers used in cDNA synthesis and PCR ampli-
ication were based on the genomic sequence of GBV-B
Simons et al., 1995b). Long RT–PCR was performed by
sing Superscript II reverse transcriptase (GIBCO/BRL)
nd the Advantage cDNA polymerase mix (Clontech) as
escribed previously (Tellier et al., 1996). Four sub-
enomic regions of GBV-B covering the entire published
equence (Simons et al., 1995b) were amplified from
erum and the PCR products were purified and cloned
nto pGEM-9Zf(2) (Promega) or pCR2.1 vector (Invitro-
en) using standard procedures.
The 59 terminus of GBV-B was amplified from serum by
sing the 59 RACE with dC or dA tailing (GIBCO/BRL) and
BV-B-specific antisense primers. To determine the 39
erminal sequence of GBV-B, two different approaches
ere used. In one approach GBV-B RNA extracted from
erum was circularized with T4 RNA ligase (Promega)
nd the 59-to-39-end-ligated viral RNA was amplified in
T-PCR using specific GBV-B primers. In the second
pproach, the 59 end of the negative strand GBV-B RNA
xtracted from the liver homogenate was amplified by
sing the 59 RACE with dC tailing and GBV-B-specific
ense primers. The PCR products were cloned directly
nto pCR2.1-TOPO by using the TOPO TA Cloning Kit
Invitrogen).
The consensus sequence of GBV-B was determined
y direct sequencing of PCR products (nts 1–9078 and
130–9359) and by sequence analysis of clones (nts
–7135 and 7151–9399). Nucleotide positions correspond
o those of the infectious clone (pGBB) reported in this
aper. Analyses of genomic sequences were performed
ith GeneWorks (Oxford Molecular Group) (Bukh et al.,
995). The predicted secondary structures of the GBV-B
nd HCV 39 UTR sequences were determined by the
rogram “mFold” (Genetics Computer Group).
Testing for GBV-B was performed by an RT-nested PCR
ssay with primers from the 59 UTR (external primer pair:
9-CCT AGC AGG GCG TGG GGG ATT TCC-39 and 59-
GG TCT GCG TCC TTG GTA GTG ACC-39; internal
rimer pair: 59-GGA TTT CCC CTG CCC GTC TG-39 and
9-CCC CGG TCT TCC CTA CAG TG-39). The RT was
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477INFECTIOUS CLONE OF GB VIRUS-Berformed with avian myeloblastosis virus reverse tran-
criptase (Promega), and the external anti-sense primer
nd nested PCR was performed with AmpliTaq DNA
olymerase or AmpliTaq Gold DNA polymerase (Perkin–
lmer) as described in detail previously (Bukh et al.,
998a,b). Specificity was confirmed by sequence analy-
is of selected DNA products. Each set of experiments
ncluded a positive control sample [a 1026 dilution of the
B 8/93 serum pool, estimated titer 100 genome equiv-
lents (GE)] and appropriate negative control samples.
he GE titer of GBV-B in positive samples was deter-
ined by RT-nested PCR on 10-fold serial dilutions of the
xtracted RNA (Bukh et al., 1998b). One GE was defined
s the number of GBV-B genomes present in the highest
ilution positive in RT-nested PCR. Testing for GBV-A and
BV-A variants was performed by RT-nested PCR assays
s described previously (Bukh and Apgar, 1997).
onstruction of consensus cDNA clones of GBV-B
We first constructed a consensus clone of GBV-B,
lone pGBB5–1, which had the 39 terminus of GBV-B as
ublished by Simons et al. (1995b). The core sequence of
he T7 promoter, a 59 guanosine residue and the se-
uence of GBV-B (9139 nts) were cloned into pGEM-
Zf(2) vector using NotI and SacI sites. A BamHI site
as included at the GBV-B 39 terminus. Digested frag-
ents containing the consensus sequence were purified
rom subclones and ligated using convenient sites. A
econd consensus clone of GBV-B, clone pGBB, was
onstructed by inserting the new 39 UTR sequence, am-
lified by PCR from one of the clones obtained by the
ACE procedure, into pGBB5–1 by using XmaI (at posi-
ion 9114) and BamHI sites. A XhoI site was inserted
ollowing the GBV-B 39 terminus. DH5a competent cells
GIBCO BRL) were transformed and selected on LB agar
lates containing 100 mg/ml ampicillin (SIGMA) and am-
lified in LB liquid cultures at 30°C for 18–20 h (Yanagi et
l., 1997). Each cDNA clone was retransformed to select
single clone, and large-scale preparation of plasmid
NA was performed with a QIAGEN plasmid Maxi kit as
escribed previously (Yanagi et al., 1997). Each clone
as genetically stable because the digestion pattern
as as expected after retransformation and the com-
lete sequence was the expected one.
ntrahepatic transfection of tamarins (S. mystax) with
ranscribed GBV-B RNA
In 100 ml reactions, RNA was transcribed in vitro with
7 RNA polymerase (Promega) from 10 mg of linearized
emplate plasmid. The plasmid pGBB5–1 was linearized
ith BamHI (Promega), and the plasmid pGBB was lin-
arized with XhoI (Promega). The integrity of the RNA
as checked by electrophoresis through agarose gel
tained with ethidium bromide. Each transcription mix-
ure was diluted with 400 ml of ice-cold phosphate-uffered saline without calcium or magnesium (SIGMA)
nd then immediately frozen on dry ice and stored at
80°C. Within 24 h, two transcription mixtures were
njected into each tamarin by percutaneous intrahepatic
njection guided by ultrasound (Yanagi et al., 1998, 1999).
f the tamarin did not become infected, the same trans-
ection was repeated once. All transfected animals were
egative for GBV-A and GBV-A variants (Bukh and Apgar,
997).
ransmission studies in tamarins
We primarily used tamarins of the species Saguinus
ystax. A single tamarin of the species S. oedipus was
lso used. Animals were maintained under conditions
hat met or exceeded all requirements for their use in an
pproved facility. Serum samples were collected weekly
rom the tamarins and monitored for liver enzyme levels
alanine aminotransferase (ALT), g-glutamyltranspepti-
ase (GGT), and isocitrate dehydrogenase (ICD)] by
tandard methods. In addition, liver biopsy samples were
ollected weekly from the two transfected animals, and
ixed liver tissue was examined for necroinflammatory
hanges.
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